Optimal time-points in clinical trials with linearly divergent treatment effects

Statistics in Medicine

Volumn 24, Issue 24, 2005, Pages 3743-3756

  Winkens, Bjorn ^a   Schouten, Hubert J A ^a   van Breukelen, Gerard J P ^a   Berger, Martin P F ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Allocation of time points; Compound symmetry; First order auto regression; Linear divergence; Repeated measures

Indexed keywords

ARTICLE; CLINICAL STUDY; COVARIANCE; DECISION MAKING; LINEAR SYSTEM; MEASUREMENT ERROR; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL CONCEPTS; SYSTEMATIC ERROR; TREATMENT OUTCOME;

CLINICAL TRIALS; ENDPOINT DETERMINATION; HUMANS; MODELS, STATISTICAL; NETHERLANDS; TREATMENT OUTCOME;

EID: 30944465842     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2385     Document Type: Article

References (26)

1. Bloch DA. Sample size requirements and the cost of a randomized clinical trial with repeated measurements. Statistics in Medicine 1988; 5:663-667.
2. Lui K-J, Cumberland WG. Sample size requirement for repeated measurements in continuous data. Statistics in Medicine 1992; 11:633-641.
3. Schouten HJA. Planning group sizes in clinical trials with a continuous outcome and repeated measures. Statistics in Medicine 1999; 18:255-264.
4. Yi Q, Panzarella T. Estimating sample size for tests on trends across repeated measurements with missing data based on the interaction term in a mixed model. Controlled Clinical Trials 2002; 23:481-496.
5. Jung S-H, Ahn C. Sample size estimation for GEE method for comparing slopes in repeated measurements data. Statistics in Medicine 2003; 22:1305-1315.
6. Liu X. Statistical power and optimum sample allocation ratio for treatment and control having unequal costs per unit of randomization. Journal of Educational and Behavioral Statistics 2003; 28:231-248.
7. Schlesselman JJ. Planning a longitudinal study. II. Frequency of measurement and study duration. Journal of Chronic Diseases 1973; 26:561-570.
8. Maxwell SE. Longitudinal designs in randomized group comparisons: when will intermediate observations increase statistical power? Psychological Methods 1998; 3:275-290.
9. Arndt S, Jorge R, Turvey C, Robinson RG. Adding subjects or adding measurements: which increases the precision of longitudinal research? Journal of Psychiatric Research 2000; 34:449-455.
10. Raudenbush SW, Liu X-F. Effects of study duration, frequency of observation, and sample size on power in studies of group differences in polynomial change. Psychological Methods 2001; 6:387-401.
11. Vickers AJ. How many repeated measures in repeated measures designs? Statistical issues for comparative trials. BMC Medical Research Methodology 2003; 3:22.
12. Tan FES, Berger MPF. Optimal allocation of time points for the random effects model. Communications in Statistics, Simulations and Computations 1999; 28:517-540.
13. Ouwens MJNM, Tan FES, Berger MPF. Maximin D-optimal designs for longitudinal mixed effects models. Biometrics 2002; 58:735-741.
14. Overall JE, Doyle SR. Estimating sample sizes for repeated measurement designs. Controlled Clinical Trials 1994; 15:100-123.
15. Feighner JP. Trazodone, a triazolopyridine derivative, in primary depressive disorder. Journal of Clinical Psychiatry 1980; 41:250-255.
16. Jennrich RI, Schluchter MD. Unbalanced repeated-measures models with structured covariance matrices. Biometrics 1986; 42:805-820.
17. Diggle PJ. Time Series: A Biostatistical Introduction. Clarendon Press: Oxford, 1990.
18. Gruttola V, Lange N, Dafni U. Modeling the progression of HIV infection. Journal of the American Statistical Association 1991; 86:569-577.
19. Raudenbush SW, Chan W. Application of hierarchical linear model to the study appendix of adolescent deviance in an overlapping cohort design. Journal of Clinical and Consulting Psychology 1993; 61:941-951.
20. Frison LJ, Pocock SJ. Linearly divergent treatment effects in clinical trials with repeated measures: efficient analysis using summary statistics. Statistics in Medicine 1997; 16:2855-2872.
21. Furberg CD, Adams HP, Applegate WB et al. Corony heart disease/myocardial infarction: effect of Lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 1994; 90:1679-1687.
22. Diggle PJ, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. Clarendon Press: Oxford, 1996.
23. Atkinson AC, Donev AN. Optimum Experimental Designs. Clarendon Press: Oxford, 1996.
24. Hoffman DR, Locke KG, Wheaton DH, Fish GE et al. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. American Journal of Ophthalmology 2004; 137:704-718.
25. Everitt BS. The analysis of repeated measures: a practical review with examples. The Statistician 1995; 44:113-135.
26. Searle SR, Casella G, McCulloch CE. Variance Components. Wiley: New York, 1992; 239.